Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Rydyznski Moderbacher, Carolyn, Ramirez, Sydney I., Dan, Jennifer M., Grifoni, Alba, Hastie, Kathryn M., Weiskopf, Daniela, Belanger, Simon, Abbott, Robert K. +16 more·2020·Cell
DOI 10.1016/j.cell.2020.09.038

Cited by (1,001)

Items 201–300 of 1,001

  1. Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
    Abayasingam, Arunasingam, Balachandran, Harikrishnan, Agapiou, David, Hammoud, Mohamed, Rodrigo, Chaturaka, Keoshkerian, Elizabeth, Li, Hui, Brasher, Nicholas A., Christ, Daniel, Rouet, Romain et al. · 2021 · Cell Reports Medicine
  2. SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
    Syed Faraz Ahmed, Ahmed Abdul Quadeer, Matthew R. McKay · 2022 · Viruses
  3. COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review
    Jessica Jones, Aiman J. Faruqi, James Sullivan, Cassandra M. Calabrese, Leonard H. Calabrese · 2021 · Pathogens and Immunity
  4. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries
    Kaiming Wang, Mahmoud Gheblawi, Anish Nikhanj, Matthew Munan, Erika MacIntyre, Conar O’Neil, Marko Poglitsch, Daniele Colombo, Franca Del Nonno, Zamaneh Kassiri et al. · 2021 · Hypertension
  5. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers
    Ricardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, Esther Dawen Yu, José Mateus, Lorenzo G. Quiambao, Eric W. Wang, Stephen A. Rawlings, Daniel Stadlbauer, Kaijun Jiang et al. · 2021 · The Journal of Infectious Diseases
  6. Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
    Chiara Corti, Gabriele Antonarelli, Florian Scotté, Jean‐Philippe Spano, Jérôme Barrière, Jean‐Marie Michot, Fabrice André, Giuseppe Curigliano · 2021 · Annals of Oncology
  7. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
    Nina Koerber, Alina Priller, Sarah Yazici, Tanja Bauer, Cho‐Chin Cheng, Hrvoje Mijočević, Hannah Wintersteller, Samuel D. Jeske, Emanuel Vogel, Martin Feuerherd et al. · 2022 · Nature Communications
  8. Hematopoietic responses to SARS-CoV-2 infection
    Shokrollah Elahi · 2022 · Cellular and Molecular Life Sciences
  9. Dysregulated hematopoiesis in bone marrow marks severe COVID-19
    Xin Wang, Yanling Wen, Xiaowei Xie, Yang Liu, Xiao-Hua Tan, Qing-Xian Cai, Ya-Wen Zhang, Lin Cheng, Gang Xu, Shengyuan Zhang et al. · 2021 · Cell Discovery
  10. T cell immunity to SARS-CoV-2
    Julia Niessl, Takuya Sekine, Marcus Buggert · 2021 · Seminars in Immunology
  11. Advances and gaps in SARS-CoV-2 infection models
    César Muñoz‐Fontela, Lina Widerspick, Randy A. Albrecht, Martin Beer, Miles W. Carroll, Emmie de Wit, Michael Diamond, William E. Dowling, Simon G. P. Funnell, Adolfo García‐Sastre et al. · 2022 · PLoS Pathogens
  12. The role of B cells in COVID-19 infection and vaccination
    Shiru Chen, Fei Guan, Fabio Candotti, Kamel Benlagha, Niels Olsen Saraiva Câmara, Andrés A. Herrada, Louisa Katherine James, Jiahui Lei, Heather Miller, Masato Kubo et al. · 2022 · Frontiers in Immunology
  13. Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody
    Tanushree Dangi, Sarah Sanchez, Jacob Class, Michelle Richner, Lavanya Visvabharathy, Young Rock Chung, Kirsten Bentley, Richard James Stanton, Igor Jerome Koralnik, Justin M. Richner et al. · 2022 · Journal of Clinical Investigation
  14. In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
    Muhammad Saqib Sohail, Syed Faraz Ahmed, Ahmed Abdul Quadeer, Matthew R. McKay · 2021 · Advanced Drug Delivery Reviews
  15. Cellular Immune Response to COVID-19 and Potential Immune Modulators
    Xi Kathy Zhou, Qing Ye · 2021 · Frontiers in Immunology
  16. Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders
    Céline Louapre, Michella Ibrahim, Élisabeth Maillart, Basma Abdi, Caroline Papeix, Bruno Stankoff, Anne‐Laure Dubessy, Caroline Bensa, Alain Créange, Zina Chamekh et al. · 2021 · Journal of Neurology Neurosurgery & Psychiatry
  17. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study
    Michael Wölfl‐Duchek, Felix Bergmann, Anselm Jorda, Maria Weber, Mathias M. Müller, Tamara Seitz, Alexander Zoufaly, Robert Paul Straßl, Markus Alexander Zeitlinger, Harald Herkner et al. · 2022 · Microbiology Spectrum
  18. Regulation of the immune system by the insulin receptor in health and disease
    Priya Makhijani, Paulo José Basso, Yi Tao Chan, Nan Chen, Jordan J. Baechle, Saad M. Khan, David Furman, Sue Jean Tsai, Daniel A. Winer · 2023 · Frontiers in Endocrinology
  19. Mechanisms underpinning poor antibody responses to vaccines in ageing
    Jia Le Lee, Michelle A. Linterman · 2021 · Immunology Letters
  20. Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection
    Rachel M. Gittelman, Enrico Lavezzo, Thomas M. Snyder, Harus Jabran Zahid, Cara L. Carty, Rebecca Elyanow, Sudeb C. Dalai, Ilan Richard Kirsch, Lance Baldo, Laura Manuto et al. · 2022 · JCI Insight
  21. A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
    Michael E. Bowdish, Christina E. Barkauskas, Jessica Overbey, Robert Gottlieb, Keren Osman, Abhijit Duggal, Mary E. Marks, Jonathan C. Hupf, Eustace Fernandes, Bradley G. Leshnower et al. · 2022 · American Journal of Respiratory and Critical Care Medicine
  22. Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
    Soumya Jaganathan, Francis Stieber, Sonia N. Rao, Vladyslav Nikolayevskyy, Davide Manissero, Nadia P.C. Allen, Jeff Boyle, Jenny Howard · 2021 · Infectious Diseases and Therapy
  23. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection
    Kohei Oishi, Shu Horiuchi, Judith M. Minkoff, Benjamin Robert tenOever · 2022 · Journal of Virology
  24. Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age
    Marion Humbert, Anna Olofsson, David Wullimann, Julia Niessl, Emma B. Hodcroft, Curtis Cai, Yu Gao, Ebba Sohlberg, Robert Dyrdak, Flora Mikaeloff et al. · 2023 · Proceedings of the National Academy of Sciences
  25. Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19
    Andrea M. Lerner, Daphne A. Robinson, Linda Yang, Carolyn Williams, Lori Marie Newman, Joseph J. Breen, Robert W. Eisinger, Johanna Sophie Schneider, Adaora A. Adimora, Emily J. Erbelding · 2021 · Annals of Internal Medicine
  26. Immunosenescence and COVID-19
    Jacek Maciej Witkowski, Tamàs Fülöp, Ewa Bryl · 2022 · Mechanisms of Ageing and Development
  27. Unique properties of tissue-resident memory T cells in the lungs: implications for COVID-19 and other respiratory diseases
    Francis R. Carbone · 2022 · Nature reviews. Immunology
  28. Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and viral vaccines
    Wenjun Zhu, Ting Wei, Yuchun Xu, Qiutong Jin, Yu Chao, Jiaqi Lu, Jun Xu, Jiafei Zhu, Xiaoying Winston Yan, Muchao Chen et al. · 2024 · Nature Communications
  29. The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
    Antonio Bertoletti, Anthony Tanoto Tan, Nina Le Bert · 2021 · Oxford Open Immunology
  30. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19
    Yunlong Ma, Fei Qiu, Chunyu Deng, Jingjing Li, Yukuan Huang, Zeyi Wu, Yijun Zhou, Yaru Zhang, Yichun Xiong, Yinghao Yao et al. · 2022 · Genome Medicine
  31. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
    Aneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, Leo Swadling, Gabriele Pollara, Rishi K Gupta, Alice R. Burton, José Afonso Guerra‐Assunção, Annemarie Woolston, Tahel Ronel et al. · 2022 · Cell Reports Medicine
  32. T cell-oriented strategies for controlling the COVID-19 pandemic
    Ji Yun Noh, Hye Won Jeong, Jérôme H. Kim, Eui‐Cheol Shin · 2021 · Nature reviews. Immunology
  33. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
    Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, Adriano Giorgio Rossi, Nicole Brace, Paul Aidan Cahill, Sandra M MacRury, Jun Wei, Ian L. Megson · 2021 · Frontiers in Cardiovascular Medicine
  34. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
    Candice Clarke, Maria F. Prendecki, Amrita Dhutia, Jaslyn Ju Lia Gan, Claire Edwards, Virginia Prout, Liz Lightstone, Eleanor L. Parker, Federica Marchesin, Megan E. Griffith et al. · 2021 · Kidney International
  35. SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus
    Giulia Matusali, Francesca Colavita, Daniele Lapa, Silvia Meschi, Licia Bordi, Pierluca Piselli, Roberta Gagliardini, Angela Corpolongo, Emanuele Nicastri, Andrea Antinori et al. · 2021 · Viruses
  36. Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose
    Nicholas S. Rhoades, Amanda N. Pinski, Alisha N. Monsibais, Allen Jankeel, Brianna M. Doratt, Isaac R. Cinco, Izabela Coimbra Ibraim, Ilhem Messaoudi · 2021 · Cell Reports
  37. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
    Hannah A. D. King, Michael Gordon Joyce, Inès Lakhal-Naouar, Aslaa Ahmed, Camila Macedo Cincotta, Caroline Subra, Kristina K. Peachman, Holly R. Hack, Rita E. Chen, Paul V. Thomas et al. · 2021 · Proceedings of the National Academy of Sciences
  38. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study
    Nicola Ivan Lorè, Rebecca DE LORENZO, Paola M. V. Rancoita, Federica Cugnata, A Agresti, Francesco Benedetti, Marco Emilio Bianchi, Chiara Bonini, Annalisa Capobianco, Caterina Conte et al. · 2021 · Molecular Medicine
  39. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
    Leanne P. M. van Leeuwen, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, Godelieve J. de Bree, Judith Potjewijd, Abraham Rutgers, Hetty Jolink, Frank L. van de Veerdonk, Eric C. M. Van Gorp, Faye de Wilt et al. · 2022 · Journal of Allergy and Clinical Immunology
  40. Understanding Immune Responses to Viruses—Do Underlying Th1/Th2 Cell Biases Predict Outcome?
    Faith Hannah Nutter Howard, Amy Kwan, Natalie Winder, Amina Mughal, Cristal Collado‐Rojas, Munitta Muthana · 2022 · Viruses
  41. A novel COVID-19 epidemiological model with explicit susceptible and asymptomatic isolation compartments reveals unexpected consequences of timing social distancing
    Jana L. Gevertz, James M. Greene, Cynthia Sanchez‐Tapia, Eduardo D. Sontag · 2020 · Journal of Theoretical Biology
  42. Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses
    Jacob K. Files, Sanghita Sarkar, Tim Fram, Sushma Boppana, Sarah Sterrett, Kai Qin, Anju Bansal, Dustin Marsh Long, Steffanie Sabbaj, James J. Kobie et al. · 2021 · JCI Insight
  43. Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults
    Jin Young Ahn, Jeongsoo Lee, You Suk Suh, Young Goo Song, Yoon-Jeong Choi, Kyoung Hwa Lee, Sang Hwan Seo, Manki Song, Jong‐Won Oh, Minwoo Kim et al. · 2022 · The Lancet Microbe
  44. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents
    Jie Zhang, Hao Lin, Beiwei Ye, Min Jie Zhao, Jianbo Zhan, Shaobo Dong, Yaxin Guo, Yingze Zhao, Min Li, Sai Liu et al. · 2021 · Clinical Infectious Diseases
  45. Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae
    Ryan C. Thompson, Nicole W. Simons, Lillian Wilkins, Esther Cheng, Diane Marie Del Valle, Gabriel E. Hoffman, Carlo Cervia, Brian Fennessy, Konstantinos Mouskas, Nancy J. Francoeur et al. · 2022 · Nature Medicine
  46. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
    Fernando Gónzález‐Candelas, Marie‐Anne Shaw, Tung Gia Phan, Urmila Kulkarni‐Kale, Dimitrios N. Paraskevis, Fabio Luciani, Hirokazu Kimura, Manuela Sironi · 2021 · Infection Genetics and Evolution
  47. COVID-19 Pathogenesis and Clinical Manifestations
    R Alfonso Hernandez Acosta, Zerelda Esquer Garrigos, Jasmine Riviere Marcelin, Prakhar Vijayvargiya · 2022 · Infectious Disease Clinics of North America
  48. A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile
    Wandong Hong, Xiaoying Zhou, Shengchun Jin, Yajing Lu, Jingyi Pan, Qingyi Lin, Shaopeng Yang, Tingting Xu, Zarrin Basharat, Maddalena Zippi et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  49. Defending against SARS-CoV-2: The T cell perspective
    Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal · 2023 · Frontiers in Immunology
  50. Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
    Grace Kenny, Liam Townsend, Stefano Savinelli, Patrick W. G. Mallon · 2023 · Frontiers in Molecular Biosciences
  51. Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant
    Rofhiwa Nesamari, Millicent A. Omondi, Richard Baguma, Maxine A. Höft, Amkele Ngomti, Anathi A. Nkayi, Asiphe S. Besethi, Siyabulela F. J. Magugu, Paballo Mosala, Avril Walters et al. · 2024 · Cell Host & Microbe
  52. Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
    Kathleen M. Wragg, Wen Shi Lee, Marios Koutsakos, Hyon‐Xhi Tan, Thakshila H. Amarasena, Arnold Reynaldi, Grace Gare, Penny Konstandopoulos, Kirsty R. Field, Robyn Esterbauer et al. · 2022 · Nature Immunology
  53. Immunosenescence and inflamm-ageing in COVID-19
    Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Mohsen Ghiasi, Hamid Kooshki, Mozafar Mohammadi, Jafar Amani, Nima Rezaei · 2022 · Ageing Research Reviews
  54. SARS-CoV-2-specific immune response in COVID-19 convalescent individuals
    Yunbao Pan, Xianghu Jiang, Liu Yang, Liangjun Chen, Xiaojiao Zeng, Guohong Liu, Yueting Tang, Chungen Qian, Xinming Wang, Fangming Cheng et al. · 2021 · Signal Transduction and Targeted Therapy
  55. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
    Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Francesco Annunziato, Lorenzo Cosmi · 2021 · Seminars in Immunology
  56. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
    Stéphane Pillet, Prabhu S. Arunachalam, Guadalupe Andreani, Nadia Golden, Jane A. Fontenot, Pyone P. Aye, Katharina Röltgen, Gabrielle Lehmicke, Philipe Gobeil, Charlotte Dubé et al. · 2022 · Cellular and Molecular Immunology
  57. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
    Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, Asmaa Hachim, Yanmei Zhang, Sau Man Chan, Sara Chaothai et al. · 2022 · Nature Communications
  58. SARS-CoV-2 infection in children and implications for vaccination
    Jordan Nathanielsz, Zheng Quan Toh, Lien Anh Ha Do, Kim Mulholland, Paul Vincent Licciardi · 2022 · Pediatric Research
  59. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
    Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, Josue Marquez, Dillon R. Flebbe, Anna Mychalowych, Evan Lamb, Meredith E. Davis-Gardner, Matthew R. Burnett, Leonid Serebryannyy et al. · 2024 · Nature Immunology
  60. The dark side of Tregs during aging
    Palatella, Martina, Guillaume, Stephane M., Linterman, Michelle A., Huehn, Jochen · 2022 · Frontiers in Immunology
  61. Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
    Moraima Jiménez, Elisa Roldán, Candela Fernández‐Naval, Guillermo Javierre Villacampa, Mónica Martínez‐Gallo, Daniel Medina-Gil, Soraya Peralta, Gemma Pujadas, Cristina Hernández, Carlota Pagès et al. · 2021 · Blood Advances
  62. CD8+ T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer
    Valentina Tedeschi, Giorgia Paldino, Martina Kunkl, Marino Paroli, Rosa Sorrentino, Loretta Tuosto, Maria Teresa Fiorillo · 2022 · International Journal of Molecular Sciences
  63. Adaptive immunity to SARS-CoV-2 infection: A systematic review
    Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, Luana Nepomuceno Gondim Costa Lima · 2022 · Frontiers in Immunology
  64. Host Recovery from Respiratory Viral Infection
    Xiaoqin Wei, Harish Narasimhan, Bibo Zhu, Jie Sun · 2023 · Annual Review of Immunology
  65. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity
    Eunok Lee, Kerrie J. Sandgren, Gabriel Duette, Vicki V Stylianou, Rajiv Khanna, John‐Sebastian Eden, Emily Blyth, David J. Gottlieb, Anthony Lawrence Cunningham, Sarah Palmer · 2020 · Journal of Virology
  66. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
    Matthew K. Siggins, Ryan S. Thwaites, Peter Openshaw · 2021 · Trends in Microbiology
  67. The Quality of SARS-CoV-2–Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated
    Shima Shahbaz, Lai Xu, Wendy Sligl, Mohammed S. Osman, Najmeh Bozorgmehr, Siavash Mashhouri, Desiree Redmond, Eliana Perez Rosero, John W. T. Walker, Shokrollah Elahi · 2021 · The Journal of Immunology
  68. HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave
    Farina Karim, Inbal Gazy, Sandile Cele, Yenzekile Zungu, Robert Krause, Mallory P. Bernstein, Khadija Khan, Yashica Ganga, Hylton E. Rodel, Ntombifuthi Mthabela et al. · 2021 · eLife
  69. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
    Kanika Vanshylla, Chengcheng Fan, Marie Wunsch, Nareshkumar Poopalasingam, Matthijs Meijers, Christoph Kreer, Franziska Kleipass, Denis Ruchnewitz, Meryem Seda Ercanoglu, Henning Gruell et al. · 2021 · Cell Host & Microbe
  70. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
    Patricia Almendro-Vázquez, Rocío Laguna‐Goya, María Ruiz‐Ruigómez, Alberto Utrero‐Rico, Antonio Lalueza, Guillermo Maestro de la Calle, Pilar Delgado, Luis Pérez Ordoño, Eva Muro, Juan José Vila et al. · 2021 · PLoS Pathogens
  71. SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
    Kimberly Ann Kraynyak, Elliott Blackwood, Joseph T. Agnes, Pablo Tebas, Mary Giffear, Dinah H. Amante, Emma L. Reuschel, Mansi Purwar, Aaron Christensen-Quick, Neiman Liu et al. · 2022 · The Journal of Infectious Diseases
  72. The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
    Feng Chen, Yan‐Ting Chen, Yongxiang Wang, Qiongwei Ke, Lili Cui · 2022 · Translational Neurodegeneration
  73. Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
    Yongjun Sui, Yonas Bekele, Jay A. Berzofsky · 2021 · Pathogens
  74. Epidemiology and Clinical Presentation of COVID-19 in Older Adults
    Yasin Abul, Ciera Leeder, Stefan Gravenstein · 2022 · Clinics in Geriatric Medicine
  75. Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection
    Ismail Cem Yilmaz, Emre Mert İpekoğlu, Artun Bulbul, Nilsu Turay, Muzaffer Yıldırım, İrem Evcili, Naz Surucu Yilmaz, Nese Guvencli, Yagmur Aydin, Bilgi Gungor et al. · 2021 · Allergy
  76. SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing
    Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, Stanley W. Botchway, Wayne D. Frasch, Edward J. Calabrese, Jimmy David Bell · 2020 · Immunity & Ageing
  77. Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients
    Jonathan Youngs, Nicholas M. Provine, Nicholas T. Y. Lim, Hannah Sharpe, Ali Amini, Yi‐Ling Chen, Jian Fei Luo, Matthew D. Edmans, Panagiota Zacharopoulou, Wentao Chen et al. · 2021 · PLoS Pathogens
  78. SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals
    Alessandra Ruggiero, Chiara Piubelli, Lucia Calciano, Simone Accordini, Maria Teresa Valenti, Luca Dalle Carbonare, Gabriel Siracusano, Lucia Lopalco, Nigel James Temperton, Natalia Tiberti et al. · 2022 · EBioMedicine
  79. Understanding COVID-19 in children: immune determinants and post-infection conditions
    Gioacchino Andrea Rotulo, Paolo Palma · 2023 · Pediatric Research
  80. T cell immune memory after covid-19 and vaccination
    Lulu Wang, Alexander R. Nicols, Lance C. W. Turtle, Alex G Richter, Christopher James Arthur Duncan, Susanna Jane Dunachie, Paul Klenerman, Rebecca Payne · 2023 · BMJ Medicine
  81. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
    Delia Goletti, Linda Petrone, Davide Manissero, Antonio Bertoletti, Sonia N. Rao, Nduku Ndunda, Alessandro Sette, Vladyslav Nikolayevskyy · 2021 · Clinical Microbiology and Infection
  82. Extending human healthspan and longevity: a symposium report
    Loren M. DeVito, Nir Barzilai, Ana María Cuervo, Laura J. Niedernhofer, Sofiya Milman, Morgan E. Levine, Daniel Promislow, Luigi Ferrucci, George A. Kuchel, Joan B. Mannick et al. · 2021 · Annals of the New York Academy of Sciences
  83. Impact of rituximab on COVID-19 outcomes
    Hannah Levavi, Guido Lancman, Janice Lynn Gabrilove · 2021 · Annals of Hematology
  84. A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections
    Sarah C. Vick, Marie Frutoso, Florian Mair, A Konecny, Evan Greene, Caitlin R. Wolf, Jennifer K. Logue, Nicholas Franko, Jim B. Boonyaratanakornkit, Raphaël Gottardo et al. · 2021 · Science Advances
  85. Neutralizing Antibody-Independent SARS-CoV-2 Control Correlated with Intranasal Vaccine-Induced CD8 + T-Cell Responses
    Hiroshi Ishii, Takushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, Trang Thi Thu Hau, Shigeyoshi Harada, Sayuri Seki, Midori Nakamura‐Hoshi, Midori Okazaki, Sachie Daigen et al. · 2021 · Cell Reports Medicine
  86. B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination
    Prasanti Kotagiri, Federica Mescia, William M. Rae, Laura Bergamaschi, Zewen Kelvin Tuong, Lorinda Turner, Kelvin Hunter, Pehuén Pereyra Gerber, Myra D.T. Hosmillo, Christoph Hess et al. · 2022 · Cell Reports
  87. Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern
    Rajesh Vikkurthi, Asgar Ansari, Anupama Ramakanth Pai, Someshwar Nath Jha, Shilpa Sachan, Suvechchha Pandit, Bhushan Nikam, Anurag Kalia, Bimal Prasad Jit, Hilal Ahmad Parray et al. · 2022 · Nature Microbiology
  88. Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis
    Xi Wu, Lu Wang, Lu Shen, Kefu Tang · 2022 · EBioMedicine
  89. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
    C. Le Nouën, Christine E. Nelson, Xue-Qiao Liu, Hong-Su Park, Y. Matsuoka, Cindy Luongo, Celia Santos, Li-Juan Yang, Richard Herbert, Ashley Castens et al. · 2022 · Cell
  90. Defining the balance between optimal immunity and immunopathology in influenza virus infection
    Thi H. O. Nguyen, Louise C. Rowntree, Brendon Yew Loong Chua, Ryan S. Thwaites, Katherine Kedzierska · 2024 · Nature reviews. Immunology
  91. Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine
    Chiara Agrati, Concetta Castilletti, Delia Goletti, Silvia Meschi, Alessandra Sacchi, Giulia Matusali, Veronica Bordoni, Linda Petrone, Daniele Lapa, Stefania Notari et al. · 2021 · Microorganisms
  92. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
    Ioannis P. Trougakos, Evangelos Terpos, Christina Zirou, Aimilia D. Sklirou, Filia Apostolakou, Sentiljana Gumeni, Ioanna Charitaki, Eleni‐Dimitra Papanagnou, Tina Bagratuni, Christine‐Ivy Liacos et al. · 2021 · BMC Medicine
  93. SARS-CoV-2 epitope–specific CD4 + memory T cell responses across COVID-19 disease severity and antibody durability
    Ryan W. Nelson, Yuezhou Chen, Olivia L. Venezia, Richard M. Majerus, Daniel Sanghoon Shin, MGH COVID-19 Collection & Processing Team, Mary N Carrington, Xu G. Yu, Duane R. Wesemann, James J. Moon et al. · 2022 · Science Immunology
  94. NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses
    Carolyn Rydyznski Moderbacher, Christina Kim, José Mateus, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Daniela Weiskopf, Alessandro Sette, Louis F Fries, Gregory M. Glenn et al. · 2022 · Journal of Clinical Investigation
  95. Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
    Liu, Jun, Budylowski, Patrick, Samson, Reuben, Griffin, Bryan D., Babuadze, Giorgi, Rathod, Bhavisha, Colwill, Karen, Abioye, Jumai A., Schwartz, Jordan A., Law, Ryan et al. · 2022 · Science Advances
  96. A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant
    Jun Wu, Lang Zhao, Bei-Bei Han, Hong‐Guo Hu, Bo-Dou Zhang, Wen-Hao Li, Yong‐Xiang Chen, Yanmei Li · 2020 · Chemical Communications
  97. Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2
    Krystle K. Q. Yu, Stephanie Fischinger, Malisa T. Smith, Caroline G. Atyeo, Deniz Cizmeci, Caitlin R. Wolf, Erik D. Layton, Jennifer K. Logue, Melissa S. Aguilar, Kiel D. Shuey et al. · 2021 · JCI Insight
  98. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
    Linda Petrone, Elisa Petruccioli, Tonino Alonzi, Valentina Vanini, Gilda Cuzzi, Saeid Najafi Fard, Concetta Castilletti, Fabrizio Palmieri, Gina Gualano, Pietro Vittozzi et al. · 2021 · Journal of Infection
  99. Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens
    Vijayashree Mysore, Xavier Culleré, Matthew Lee Settles, Xinge Ji, Michael W. Kattan, Michaël Desjardins, Blythe P Durbin-Johnson, Tal Gilboa, Lindsey Robert Baden, David R. Walt et al. · 2021 · Med
  100. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
    Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara · 2021 · Viruses